Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients

<p>Abstract</p> <p>Background</p> <p>New biomarkers that replace or are used in conjunction with the current ovarian cancer diagnostic antigen, CA125, are needed for detection of ovarian cancer in the presurgical setting, as well as for detection of disease recurrence....

Full description

Bibliographic Details
Main Authors: Andersen John D, Boylan Kristin LM, Jemmerson Ronald, Geller Melissa A, Misemer Benjamin, Harrington Katherine M, Weivoda Starchild, Witthuhn Bruce A, Argenta Peter, Vogel Rachel, Skubitz Amy PN
Format: Article
Language:English
Published: BMC 2010-09-01
Series:Journal of Ovarian Research
Online Access:http://www.ovarianresearch.com/content/3/1/21